EXR could unlock a new sub basin at its Mongolian Gas Project

|

Published 23-OCT-2020 09:58 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Elixir Energy Limited (ASX:EXR) has provided an update on its 100% owned Nomgon IX CBM PCS, located in the south Gobi region of Mongolia, just North of the Chinese border.

It should be noted that China’s energy demand is significant and its gas market continues grow. This month, President Xi Jinping committed his country to net-zero emissions by 2060.

Given its location, this plays right into EXR’s hands especially as China expands the country’s gas network and diversifies its energy supply.

As part of Elixir’s 2020 exploration program, the company will spud a new low-cost strat-hole (Hutul 1S).

The spud will commence tomorrow, with further planning for more wells in the following months. A second drilling rig is being added by Mongolian drilling contractor, Erdenedrilling (ED) and is being mobilised to the Hutul 1S drilling location, 20 kilometres east of the Nomgon-1 well.

This well has the potential to unlock an entirely new sub-basin, – or potentially a large extension of the Nomgon sub-basin.

For EXR, the collective sub-basins across the vast 30,000 km2 PSC could prove up a resource big enough to interest the major international gas players. To date only the small Nomgon sub-basin has hosted CSG discoveries.

EXR currently has a prospective resource of 7.6 tcf of gas (risked “best” (mid) case) over multiple sub basins and there are many other sub-basins that are yet to be explored, so there is enormous scope for significant gas reserves.

Ongoing appraisal work at the Nomgon sub-basin is continuing including laboratory work, ongoing drilling, basin modelling and seismic interpretation and planning of next year’s pilot production test.

Results and work to come

Nomgon-2 core hole’s final gas content results have been obtained from the coal samples.

These recorded dry ash free (DAF) numbers in the main seam averaging 8.6 m3/tonne. This is very similar to the 8.9 m3/t measured in the Nomgon-1 well.

Further Gas Adsorption analysis results for Nomgon 2 are expected next month, with laboratory work being undertaken and/or planned including petrography, sedimentology and age dating.

Unfortunately, the Nomgon 5S strat-hole which was spudded in September has recently encountered time delays caused by drilling and mechanical issues yielding an inability to reach total depth. Elixir and ED have agreed to redrill this strat-hole directly above its current location at a nominal cost.

EXR assures the same prognosis, as the new well will effectively be the same.

According to managing director Neil Young; “we look forward to further information from the somewhat delayed Nomgon 5S strat-hole that is still underway”.

Finally, recently acquired seismic data provides substantial indication of prospectively and enhanced assurance in the new drilling locations Elixir will be targeting in the near future.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X